(Q51474263)

5 April 2018

title

Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up. (English)

1 reference

5 April 2018

0 references

1 reference

Alvarsson M

1

1 reference

5 April 2018

Sundkvist G

2

1 reference

5 April 2018

Lager I

3

1 reference

5 April 2018

Berntorp K

4

1 reference

5 April 2018

Fernqvist-Forbes E

5

1 reference

5 April 2018

Steen L

6

1 reference

5 April 2018

Orn T

7

1 reference

5 April 2018

Holberg MA

8

1 reference

5 April 2018

Kirksaether N

9

1 reference

5 April 2018

Grill V

10

1 reference

5 April 2018

publication date

29 March 2007

1 reference

5 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

5 April 2018

volume

10

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

page(s)

421-429

1 reference

5 April 2018

Overstimulation and beta-cell function

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Pancreatic beta-cell loss and preservation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Sulfonylurea induced beta-cell apoptosis in cultured human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Is there a concentration-effect relationship for sulphonylureas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Combination therapies with insulin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00719.X

10.1111/J.1463-1326.2007.00719.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

17394534

1 reference

5 April 2018